Cargando…

Predicted uptake of COVID-19 vaccination in USA

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016609/ https://www.ncbi.nlm.nih.gov/pubmed/33824574 http://dx.doi.org/10.1007/s40274-021-7604-4

Ejemplares similares

COVID-19 vaccination predicted to be cost effective in USA
Publicado: (2021)

Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021)

Expediting COVID-19 vaccination increases QALYs and saves costs in the USA
Publicado: (2021)

Expected rates of adverse events after COVID-19 vaccination in USA
Publicado: (2022)

COVID-19 a substantial burden for hospitals and patients in the USA
Publicado: (2021)

Costs of ICU care during COVID-19 pandemic in USA
Publicado: (2021)

Expanded testing for COVID-19 could be cost effective in USA
Publicado: (2020)

Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
por: Mello, Michelle M, et al.
Publicado: (2022)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Remote pulse-ox monitoring for COVID-19 patients saves costs, improves outcomes in the USA
Publicado: (2021)

FAPIC score predicts mortality after COVID-19 vaccine-related TTS
Publicado: (2021)

Disparities in COVID-19 Vaccine Booster Uptake in the USA: December 2021–February 2022
por: Gaffney, Adam, et al.
Publicado: (2022)

WTP for COVID-19 vaccine in Chile
Publicado: (2021)

TTS with Janssen's COVID-19 vaccine
Publicado: (2021)

A cluster randomised feasibility study of an adolescent incentive intervention to increase uptake of HPV vaccination
por: Forster, Alice S, et al.
Publicado: (2017)

Public's willingness to wait for COVID-19 vaccine
Publicado: (2021)

Willingness to pay for COVID-19 vaccination in China
Publicado: (2021)

COVID-19 vaccination safe during pregnancy
Publicado: (2021)

Thrombocytopenia and thromboembolism after COVID-19 vaccination
Publicado: (2021)

Anxiety disorders with Janssen's COVID-19 vaccine
Publicado: (2021)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

Heterogeneity in potential COVID-19 vaccine-related AEs
Publicado: (2021)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

Association of Sources of COVID-19 Information with Vaccine Uptake, Preventive Behaviors, and Perceived Severity of COVID-19
por: Kim, Yeunkyung, et al.
Publicado: (2023)

COVID-19 vaccines safe in people living with HIV
Publicado: (2022)

Systemic AEs common after COVID-19 vaccination
Publicado: (2022)

Acute neurological AEs after COVID-19 vaccination
Publicado: (2022)

COVID-19 vaccination relatively safe in autoimmune diseases
Publicado: (2022)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

Productivity losses impact cost effectiveness of COVID-19 vaccine
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021)

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)

Cerebral venous sinus thrombosis after COVID-19 vaccination
Publicado: (2021)

COVID-19 vaccine adverse events reported via app
Publicado: (2021)

COVID-19 vaccination during pregnancy: no increase in placental lesions
Publicado: (2021)

Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia
Publicado: (2021)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ueo2s9ttn5v9s7qdl28at6g25e